Monitoring Tumor Recurrence with Nasopharyngeal Swab and Latent Membrane Protein-1 and Epstein-Barr Nuclear Antigen-1 Gene Detection in Treated Patients with Nasopharyngeal Carcinoma
✍ Scribed by Sheng-Po Hao; Ngan-Ming Tsang; Kai-Ping Chang
- Book ID
- 110087477
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 93 KB
- Volume
- 114
- Category
- Article
- ISSN
- 0023-852X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Background: Nasopharyngeal carcinoma (npc) is the most common head and neck malignancy in southeastern china and taiwan. early detection of the local disease followed by timely and appropriate treatment is essential to increasing cure and survival rates. detection of epstein-barr virus (ebv) gen
## Abstract Latent membrane protein 1 (LMP‐1) is an Epstein‐Barr virus‐encoded oncoprotein expressed in ∼50–70% of nasopharyngeal carcinoma (NPC). Previous studies have shown that NPC‐derived LMP‐1 variants carrying 30 bp deletion and specific mutations in the 3′C‐terminal region confer high oncoge
## Abstract ## Background. The C‐terminal activation region 2 (CTAR2) of Epstein‐Barr virus latent membrane protein 1 is the major site that correlates with metastasis‐related signaling pathway. The variation of CTAR2 sequence may affect the incidence of distant metastasis in patients with nasopha